Literature DB >> 35478071

SKA-31-induced activation of small-conductance calcium-activated potassium channels decreased modulation of detrusor smooth muscle function in a rat model of obesity.

Jingyu Li1, Tiandong Liu2, Ning Li1, Fengming Dong1, Ping Wang3.   

Abstract

Increased excitability and contractility of detrusor smooth muscle (DSM) cells are associated with overactive bladder (OAB), which is often induced by obesity. Small-conductance Ca2+-activated K+ (SK) channels regulate the excitability and contractility of DSM cells. Selective pharmacological activation of SK channels attenuates hyperpolarization and the decreased relaxation effect in DSM cells in obesity-induced OAB. However, additional data are needed to confirm the regulatory effect of SK channels on the function of DSM cells in obesity-related OAB. The tested hypothesis was that activation of SK channels decreases modulation of DSM function in a rat model of obesity-related OAB. Female Sprague Dawley rats were fed a normal diet (ND) or a high-fat diet (HFD), weighed after 12 weeks, and subjected to urodynamic study, patch-clamp electrophysiology, and isometric tension recording. The average body weight and incidence of OAB were increased in the HFD group. Patch-clamp studies revealed that pharmacological activation of SK channels with SKA-31 had attenuated hyperpolarization of DSM cells. In addition, isometric tension recordings indicated that SKA-31 decreased relaxation of spontaneous phasic contractions of DSM strips in the HFD group. Attenuated function of SK channels increased the excitability and contractility of DSM cells, which contributed to the occurrence of OAB, suggesting that SK channels are potential therapeutic targets for control of OAB.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Detrusor smooth muscle; High-fat diet; Obesity; Overactive bladder; SK channel

Mesh:

Substances:

Year:  2022        PMID: 35478071     DOI: 10.1007/s10863-022-09939-2

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   3.853


  3 in total

Review 1.  Obesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directions.

Authors:  J Kellogg Parsons; Aruna V Sarma; Kevin McVary; John T Wei
Journal:  J Urol       Date:  2013-01       Impact factor: 7.450

Review 2.  Diabetes and benign prostatic hyperplasia/lower urinary tract symptoms--what do we know?

Authors:  Aruna V Sarma; J Kellogg Parsons; Kevin McVary; John T Wei
Journal:  J Urol       Date:  2009-12       Impact factor: 7.450

Review 3.  Exploring the relation between obesity and urinary incontinence: Pathophysiology, clinical implications, and the effect of weight reduction, ICI-RS 2018.

Authors:  Tom Marcelissen; Ralf Anding; Marcio Averbeck; Ann Hanna-Mitchell; Sajjad Rahnama'i; Linda Cardozo
Journal:  Neurourol Urodyn       Date:  2019-12       Impact factor: 2.696

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.